Base de dados : MEDLINE
Pesquisa : I01.198.240.609 [Categoria DeCS]
Referências encontradas : 147 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 15 ir para página                         

  1 / 147 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29361660
[Au] Autor:Steiner DJ; Thomson Reuters Accelus.
[Ti] Título:Pharmaceuticals and Medical Devices: Business Practices.
[So] Source:Issue Brief Health Policy Track Serv;2017:1-38, 2017 Dec 26.
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Indústria Farmacêutica/organização & administração
Farmacoeconomia
Legislação de Medicamentos
Medicamentos sob Prescrição/economia
[Mh] Termos MeSH secundário: Analgésicos Opioides
Leis Antitruste
Suplementos Nutricionais
Custos de Medicamentos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência
Medicamentos Genéricos
Epinefrina/economia
Epinefrina/uso terapêutico
Fraude
Seres Humanos
Prescrição Inadequada
Marketing de Serviços de Saúde
Medicaid
Medicare
Uso Off-Label
Patentes como Assunto
Desvio de Medicamentos sob Prescrição
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics, Opioid); 0 (Drugs, Generic); 0 (Prescription Drugs); YKH834O4BH (Epinephrine)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180219
[Lr] Data última revisão:
180219
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:180124
[St] Status:MEDLINE


  2 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29360296
[Au] Autor:Berry MD; Thomson Reuters Accelus.
[Ti] Título:Healthcare Reform: Enforcement And Compliance.
[So] Source:Issue Brief Health Policy Track Serv;2017:1-34, 2017 Dec 26.
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Fraude/prevenção & controle
Reforma dos Serviços de Saúde/organização & administração
[Mh] Termos MeSH secundário: Ambulâncias
Analgésicos Opioides
Custos de Medicamentos
Epinefrina
Serviços de Assistência Domiciliar
Seres Humanos
Prescrição Inadequada
Reembolso de Seguro de Saúde
Marketing de Serviços de Saúde
Medicaid
Medicare
Medicare Part C
Transtornos Relacionados ao Uso de Opioides
Desvio de Medicamentos sob Prescrição
Diálise Renal/economia
Delitos Sexuais
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics, Opioid); YKH834O4BH (Epinephrine)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180219
[Lr] Data última revisão:
180219
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:180124
[St] Status:MEDLINE


  3 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29049118
[Au] Autor:Webster LR
[Ad] Endereço:From PRA Health Sciences, Salt Lake City, Utah.
[Ti] Título:Risk Factors for Opioid-Use Disorder and Overdose.
[So] Source:Anesth Analg;125(5):1741-1748, 2017 Nov.
[Is] ISSN:1526-7598
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Opioid analgesics are recognized as a legitimate medical therapy for selected patients with severe chronic pain that does not respond to other therapies. However, opioids are associated with risks for patients and society that include misuse, abuse, diversion, addiction, and overdose deaths. Therapeutic success depends on proper candidate selection, assessment before administering opioid therapy, and close monitoring throughout the course of treatment. Risk assessment and prevention include knowledge of patient factors that may contribute to misuse, abuse, addiction, suicide, and respiratory depression. Risk factors for opioid misuse or addiction include past or current substance abuse, untreated psychiatric disorders, younger age, and social or family environments that encourage misuse. Opioid mortality prevalence is higher in people who are middle aged and have substance abuse and psychiatric comorbidities. Suicides are probably undercounted or frequently misclassified in reports of opioid-related poisoning deaths. Greater understanding and better assessment are needed of the risk associated with suicide risk in patients with pain. Clinical tools and an evolving evidence base are available to assist clinicians with identifying patients whose risk factors put them at risk for adverse outcomes with opioids.
[Mh] Termos MeSH primário: Analgésicos Opioides/efeitos adversos
Dor Crônica/tratamento farmacológico
Overdose de Drogas/epidemiologia
Usuários de Drogas/psicologia
Transtornos Relacionados ao Uso de Opioides/epidemiologia
Uso Indevido de Medicamentos sob Prescrição
[Mh] Termos MeSH secundário: Comportamento Aditivo
Dor Crônica/diagnóstico
Dor Crônica/epidemiologia
Dor Crônica/psicologia
Tomada de Decisão Clínica
Técnicas de Apoio para a Decisão
Overdose de Drogas/diagnóstico
Overdose de Drogas/prevenção & controle
Overdose de Drogas/psicologia
Conhecimentos, Atitudes e Prática em Saúde
Nível de Saúde
Seres Humanos
Saúde Mental
Transtornos Relacionados ao Uso de Opioides/diagnóstico
Transtornos Relacionados ao Uso de Opioides/prevenção & controle
Transtornos Relacionados ao Uso de Opioides/psicologia
Medição da Dor
Seleção de Pacientes
Desvio de Medicamentos sob Prescrição
Uso Indevido de Medicamentos sob Prescrição/prevenção & controle
Uso Indevido de Medicamentos sob Prescrição/psicologia
Medição de Risco
Fatores de Risco
Ideação Suicida
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Analgesics, Opioid)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171030
[Lr] Data última revisão:
171030
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171020
[St] Status:MEDLINE
[do] DOI:10.1213/ANE.0000000000002496


  4 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29049112
[Au] Autor:Clark DJ; Schumacher MA
[Ad] Endereço:From the *Department of Anesthesiology, Stanford University, Palo Alto, California; and †UCSF Department of Anesthesia and Perioperative Care, Division of Pain Medicine, San Francisco, California.
[Ti] Título:America's Opioid Epidemic: Supply and Demand Considerations.
[So] Source:Anesth Analg;125(5):1667-1674, 2017 Nov.
[Is] ISSN:1526-7598
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:America is in the midst of an opioid epidemic characterized by aggressive prescribing practices, highly prevalent opioid misuse, and rising rates of prescription and illicit opioid overdose-related deaths. Medical and lay public sentiment have become more cautious with respect to prescription opioid use in the past few years, but a comprehensive strategy to reduce our reliance on prescription opioids is lacking. Addressing this epidemic through reductions in unnecessary access to these drugs while implementing measures to reduce demand will be important components of any comprehensive solution. Key supply-side measures include avoiding overprescribing, reducing diversion, and discouraging misuse through changes in drug formulations. Important demand-side measures center around educating patients and clinicians regarding the pitfalls of opioid overuse and methods to avoid unnecessary exposure to these drugs. Anesthesiologists, by virtue of their expertise in the use of these drugs and their position in guiding opioid use around the time of surgery, have important roles to play in reducing patient exposure to opioids and providing education about appropriate use. Aside from the many immediate steps that can be taken, clinical and basic research directed at understanding the interaction between pain and opioid misuse is critical to identifying the optimal use of these powerful pain relievers in clinical practice.
[Mh] Termos MeSH primário: Analgésicos Opioides/efeitos adversos
Analgésicos Opioides/provisão & distribuição
Anestesiologia/métodos
Epidemias
Necessidades e Demandas de Serviços de Saúde
Transtornos Relacionados ao Uso de Opioides/epidemiologia
Dor Pós-Operatória/prevenção & controle
Uso Indevido de Medicamentos sob Prescrição
[Mh] Termos MeSH secundário: Analgésicos Opioides/química
Anestesiologia/normas
Composição de Medicamentos
Prescrições de Medicamentos
Fidelidade a Diretrizes
Conhecimentos, Atitudes e Prática em Saúde
Necessidades e Demandas de Serviços de Saúde/normas
Seres Humanos
Prescrição Inadequada
Determinação de Necessidades de Cuidados de Saúde
Transtornos Relacionados ao Uso de Opioides/diagnóstico
Transtornos Relacionados ao Uso de Opioides/prevenção & controle
Dor Pós-Operatória/diagnóstico
Dor Pós-Operatória/epidemiologia
Educação de Pacientes como Assunto
Guias de Prática Clínica como Assunto
Padrões de Prática Médica
Desvio de Medicamentos sob Prescrição/prevenção & controle
Uso Indevido de Medicamentos sob Prescrição/prevenção & controle
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Analgesics, Opioid)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171030
[Lr] Data última revisão:
171030
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171020
[St] Status:MEDLINE
[do] DOI:10.1213/ANE.0000000000002388


  5 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Texto completo
[PMID]:28447766
[Au] Autor:Saulle R; Vecchi S; Gowing L
[Ad] Endereço:Department of Epidemiology, Lazio Regional Health Service, Via di S. Costanza, Rome, Italy, 00198.
[Ti] Título:Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
[So] Source:Cochrane Database Syst Rev;4:CD011983, 2017 Apr 27.
[Is] ISSN:1469-493X
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Opioid dependence (OD) is an increasing clinical and public health problem worldwide. International guidelines recommend opioid substitution treatment (OST), such as methadone and buprenorphine, as first-line medication treatment for OD. A negative aspect of OST is that the medication used can be diverted both through sale on the black market, and the unsanctioned use of medications. Daily supervised administration of medications used in OST has the advantage of reducing the risk of diversion, and may promote therapeutic engagement, potentially enhancing the psychosocial aspect of OST, but costs more and is more restrictive on the client than dispensing for off-site consumption. OBJECTIVES: The objective of this systematic review is to compare the effectiveness of OST with supervised dosing relative to dispensing of medication for off-site consumption. SEARCH METHODS: We searched in Cochrane Drugs and Alcohol Group Specialised Register and Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, Web of Science from inception up to April 2016. Ongoing and unpublished studies were searched via ClinicalTrials.gov (www.clinicaltrials.gov) and World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (http://www.who.int/ictrp/en/).All searches included non-English language literature. We handsearched references on topic-related systematic reviews. SELECTION CRITERIA: Randomised controlled trials (RCTs), controlled clinical trials (CCTs), and prospective controlled cohort studies, involving people who are receiving OST (methadone, buprenorphine) and comparing supervised dosing with dispensing of medication to be consumed away from the dispensing point, usually without supervision. DATA COLLECTION AND ANALYSIS: We used the standard methodological procedures expected by Cochrane. MAIN RESULTS: Six studies (four RCTs and two prospective observational cohort studies), involving 7999 participants comparing supervised OST treatment with unsupervised treatment, met the inclusion criteria. The risk of bias was generally moderate across trials, but the results reported on outcomes that we planned to consider were limited. Overall, we judged the quality of the evidence from very low to low for all the outcomes.We found no difference in retention at any duration with supervised compared to unsupervised dosing (RR 0.99, 95% CI 0.88 to 1.12, 716 participants, four trials, low-quality evidence) or in retention in the shortest follow-up period, three months (RR 0.94; 95% CI 0.84 to 1.05; 472 participants, three trials, low-quality evidence). Additional data at 12 months from one observational study found no difference in retention between groups (RR 0.94, 95% CI 0.77 to 1.14; n = 300).There was no difference in abstinence at the end of treatment (self-reported drug use) (67% versus 60%, P = 0.33, 293 participants, one trial, very low-quality evidence); and in diversion of medication (5% versus 2%, 293 participants, one trial, very low-quality evidence).Regarding our secondary outcomes, we did not found a difference in the incidence of adverse effects in the supervised compared to unsupervised control group (RR 0.63; 96% CI 0.10 to 3.86; 363 participants, two trials, very low-quality evidence). Data on severity of dependence were very limited (244 participants, one trial) and showed no difference between the two approaches. Data on deaths were reported in two studies. One trial reported two deaths in the supervised group (low-quality evidence), while in the cohort study all-cause mortality was found lower in regular supervision group (crude mortality rate 0.60 versus 0.81 per 100 person-years), although after adjustment insufficient evidence existed to suggest that regular supervision was protective (mortality rate ratio = 1.23, 95% CI = 0.67 to 2.27).No studies reported pain symptoms, drug craving, aberrant opioid-related behaviours, days of unsanctioned opioid use and overdose. AUTHORS' CONCLUSIONS: Take-home medication strategies are attractive to treatment services due to lower costs, and place less restrictions on clients, but it is unknown whether they may be associated with increased risk of diversion and unsanctioned use of medication. There is uncertainty about the effects of supervised dosing compared with unsupervised medication due to the low and very low quality of the evidence for the primary outcomes of interest for this review. Data on defined secondary outcomes were similarly limited. More research comparing supervised and take-home medication strategies is needed to support decisions on the relative effectiveness of these strategies. The trials should be designed and conducted with high quality and over a longer follow-up period to support comparison of strategies at different stages of treatment. In particular, there is a need for studies assessing in more detail the risk of diversion and safety outcomes of using supervised OST to manage opioid dependence.
[Mh] Termos MeSH primário: Analgésicos Opioides/uso terapêutico
Combinação Buprenorfina e Naloxona/uso terapêutico
Terapia Diretamente Observada/métodos
Metadona/uso terapêutico
Tratamento de Substituição de Opiáceos/métodos
Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico
[Mh] Termos MeSH secundário: Analgésicos Opioides/efeitos adversos
Combinação Buprenorfina e Naloxona/efeitos adversos
Terapia Diretamente Observada/efeitos adversos
Seres Humanos
Metadona/efeitos adversos
Estudos Observacionais como Assunto
Tratamento de Substituição de Opiáceos/efeitos adversos
Desvio de Medicamentos sob Prescrição/estatística & dados numéricos
Ensaios Clínicos Controlados Aleatórios como Assunto
[Pt] Tipo de publicação:JOURNAL ARTICLE; META-ANALYSIS; REVIEW
[Nm] Nome de substância:
0 (Analgesics, Opioid); 0 (Buprenorphine, Naloxone Drug Combination); UC6VBE7V1Z (Methadone)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170802
[Lr] Data última revisão:
170802
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170428
[St] Status:MEDLINE
[do] DOI:10.1002/14651858.CD011983.pub2


  6 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28360057
[Au] Autor:Sliney MJ
[Ad] Endereço:Clinical Medical Student, University of Oxford. E-mail: matthew.sliney@magd.ox.ac.uk.
[Ti] Título:Bad medicine: red drugs.
[So] Source:Br J Gen Pract;67(657):159, 2017 04.
[Is] ISSN:1478-5242
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Dor/tratamento farmacológico
Desvio de Medicamentos sob Prescrição
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:LETTER; COMMENT
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170401
[St] Status:MEDLINE
[do] DOI:10.3399/bjgp17X690209


  7 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28179268
[Au] Autor:Dyer O
[Ti] Título:US cardiologist is sentenced to prison for plot to kill rival doctor.
[So] Source:BMJ;356:j708, 2017 Feb 08.
[Is] ISSN:1756-1833
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Conflito (Psicologia)
Homicídio
Médicos/legislação & jurisprudência
Desvio de Medicamentos sob Prescrição/legislação & jurisprudência
[Mh] Termos MeSH secundário: Homicídio/legislação & jurisprudência
Homicídio/prevenção & controle
Seres Humanos
Relações Interprofissionais
Jurisprudência
Estados Unidos
[Pt] Tipo de publicação:NEWS
[Em] Mês de entrada:1703
[Cu] Atualização por classe:170330
[Lr] Data última revisão:
170330
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170210
[St] Status:MEDLINE
[do] DOI:10.1136/bmj.j708


  8 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28150924
[Au] Autor:Drug Enforcement Administration, Department of Justice
[Ti] Título:Schedules of Controlled Substances: Extension of Temporary Placement of THJ-2201, AB-PINACA and AB-CHMINACA in Schedule I of the Controlled Substances Act. Temporary order.
[So] Source:Fed Regist;82(17):8590-2, 2017 01 27.
[Is] ISSN:0097-6326
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The Administrator of the Drug Enforcement Administration is issuing this temporary order to extend the temporary schedule I status of three synthetic cannabinoids pursuant to the temporary scheduling provisions of the Controlled Substances Act. The substances are: [1-(5-Fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201); N-1-Amino-3-methyl-1-oxo-2-butanyl]-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA); N-[1-Amino-3-methyl-1-oxo-2-butanyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), including their optical, positional and geometric isomers, salts, and salts of isomers. The current final order temporarily placing THJ-2201, AB-PINACA and AB-CHMINACA into schedule I is in effect through January 29, 2017. This order will extend the temporary scheduling of THJ-2201, AB-PINACA and AB-CHMINACA for one year, or until the permanent scheduling action for these three substances is completed, whichever occurs first.
[Mh] Termos MeSH primário: Canabinoides/classificação
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência
[Mh] Termos MeSH secundário: Seres Humanos
Desvio de Medicamentos sob Prescrição/legislação & jurisprudência
Desvio de Medicamentos sob Prescrição/prevenção & controle
Saúde Pública
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Cannabinoids)
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170203
[Lr] Data última revisão:
170203
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:170206
[St] Status:MEDLINE


  9 / 147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27980029
[Au] Autor:Thienprayoon R; Porter K; Tate M; Ashby M; Meyer M
[Ad] Endereço:The Pediatric Palliative and Comfort Care Team, Division of Pain, Department of Anesthesiology, rachel.thienprayoon@cchmc.org.
[Ti] Título:Risk Stratification for Opioid Misuse in Children, Adolescents, and Young Adults: A Quality Improvement Project.
[So] Source:Pediatrics;139(1), 2017 Jan.
[Is] ISSN:1098-4275
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: The Pediatric Palliative and Comfort Care Team (PACT) at Cincinnati Children's Hospital Medical Center (CCHMC) provides opioids to a large population of patients in the ambulatory setting. Before this project, PACT had no reliable system to risk stratify patients for opioid misuse. METHODS: The global aim was safe opioid prescribing by the palliative care team. The specific, measurable, achievable, realistic, and timely aim was as follows: "In patients who present for follow up with PACT, we will use the "opioid bundle" to increase risk stratification for opioid misuse from 0% to 90% over 5 months." The opioid bundle includes a urine drug screen, Ohio Automated Rx Reporting System report, pill count, and screening history for drug abuse and mental health disorders. The setting was multiple CCHMC ambulatory clinics. Participants included all PACT members. RESULTS: Since implementing the new system, we have increased risk stratification for opioid misuse among outpatients from 0% to >90%. Results have been sustained for 12 months. Key processes have become reliable: obtaining informed consent and controlled substance agreements for all new patients and obtaining the opioid bundle to enable risk stratification in a consistent and timely fashion. A total of 34% of patients have been stratified as high risk, and an additional 27% have been stratified as moderate risk. CONCLUSIONS: A system to ensure safe opioid prescribing practices to all patients is critical for providers. Identifying key processes and executing them reliably has enabled the palliative care team at CCHMC to risk stratify >90% of patients receiving opioids in the ambulatory setting for opioid misuse.
[Mh] Termos MeSH primário: Analgésicos Opioides/toxicidade
Analgésicos Opioides/uso terapêutico
Uso Indevido de Medicamentos sob Prescrição/prevenção & controle
Uso Indevido de Medicamentos sob Prescrição/estatística & dados numéricos
Melhoria de Qualidade/organização & administração
Medição de Risco/organização & administração
[Mh] Termos MeSH secundário: Adolescente
Criança
Feminino
Cuidados Paliativos na Terminalidade da Vida
Hospitais Pediátricos
Seres Humanos
Masculino
Ohio
Cuidados Paliativos
Desvio de Medicamentos sob Prescrição/prevenção & controle
Desvio de Medicamentos sob Prescrição/estatística & dados numéricos
Centros de Atenção Terciária
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics, Opioid)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170626
[Lr] Data última revisão:
170626
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:161217
[St] Status:MEDLINE


  10 / 147 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27797283
[Au] Autor:Egan KL; Gregory E; Sparks M; Wolfson M
[Ad] Endereço:a Department of Social Science and Health Policy , Wake Forest School of Medicine , Winston-Salem , NC , USA.
[Ti] Título:From dispensed to disposed: evaluating the effectiveness of disposal programs through a comparison with prescription drug monitoring program data.
[So] Source:Am J Drug Alcohol Abuse;43(1):69-77, 2017 Jan.
[Is] ISSN:1097-9891
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Organized disposal of controlled medications, such as take-back events and permanent drug donation boxes, is a prevention strategy that has been widely used to reduce the availability of controlled medications for diversion or abuse. However, little is known as to whether this strategy actually reduces the overall availability of these medications for the purposes of diversion or abuse. OBJECTIVES: The objective of this study was to compare the number and types of controlled medications that were disposed through organized efforts to the number dispensed in local communities. METHODS: The quantity and type of controlled medication collected from three take-back events and permanent drug donation boxes over 4-week-long periods in five counties in south-central Kentucky was measured and compared to the number of controlled medications dispensed, as reported by Kentucky All Schedule Prescription Electronic Reporting system. RESULTS: In 2013, 21,121,658 controlled medications units were dispensed in the participating counties. Of those, 46.9% were opioid analgesics, 13.1% tranquilizers, and 37.3% "other." During the assessment periods, a total of 21,503 controlled medication units were collected. Of those, 39.9% were opioid analgesics, 2.7% tranquilizers, and 57.4% "other." Annually, controlled medications disposed were estimated to account for 0.3% of those dispensed. CONCLUSION: Controlled medications collected by take-back events and permanent drug donation boxes constituted a miniscule proportion of the numbers dispensed. Our findings suggest that organized drug disposal efforts may have a minimal impact on reducing the availability of unused controlled medications at a community level.
[Mh] Termos MeSH primário: Prescrições de Medicamentos/estatística & dados numéricos
Desvio de Medicamentos sob Prescrição/estatística & dados numéricos
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:COMPARATIVE STUDY; JOURNAL ARTICLE
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161101
[St] Status:MEDLINE
[do] DOI:10.1080/00952990.2016.1240801



página 1 de 15 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde